Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Journal of Clinical Psychopharmacology|June 28, 2021
Effects of Bedtime Dosing With Suvorexant and Zolpidem on Balance and Psychomotor Performance in Healthy Elderly Participants During the Night and in the MorningHubert Bland, Xiaodong Li, Eric Mangin, et al.
Sleep Medicine|May 21, 2016
Effects of suvorexant on sleep architecture and power spectral profile in patients with insomnia: analysis of pooled phase 3 dataEllen Snyder, Junshui Ma, Vladimir Svetnik, et al.
Sleep|November 8, 2017
Insight Into Reduction of Wakefulness by Suvorexant in Patients With Insomnia: Analysis of Wake BoutsVladimir Svetnik, Ellen S Snyder, Peining Tao, et al.
Cephalalgia : an International Journal of Headache|August 10, 2014
Randomized controlled trial of the orexin receptor antagonist filorexant for migraine prophylaxisAlmira Chabi, Ying Zhang, Saheeda Jackson, et al.
Paediatric Anaesthesia|December 8, 2021
Sugammadex for reversal of neuromuscular blockade in pediatric patients: Results from a phase IV randomized studyTiffini Voss, Aobo Wang, Matthew DeAngelis, et al.
Sleep Medicine|December 8, 2018
Effects of suvorexant on the Insomnia Severity Index in patients with insomnia: analysis of pooled phase 3 dataW Joseph Herring, Kathryn M Connor, Ellen Snyder, et al.
Neurology|December 1, 2012
Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexantW Joseph Herring, Ellen Snyder, Kerry Budd, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 17, 2020
Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trialW Joseph Herring, Paulette Ceesay, Ellen Snyder, et al.
Clinical Neuropharmacology|October 24, 2017
A Phase Ib Randomized Controlled Study to Evaluate the Effectiveness of a Single-Dose of the NR2B Selective N-Methyl-D-Aspartate Antagonist MK-0657 on Levodopa-Induced Dyskinesias and Motor Symptoms in Patients With Parkinson DiseaseW Joseph Herring, Christopher Assaid, Kerry Budd, et al.
Sleep Medicine|August 8, 2013
Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover studyW Joseph Herring, Kenneth Liu, Jill Hutzelmann, et al.
Pageof 4